Skip header and navigation

1 records – page 1 of 1.

Source
J Psychosoc Nurs Ment Health Serv. 2014 Jan;52(1):12-5
Publication Type
Article
Date
Jan-2014
Author
Robert H Howland
Source
J Psychosoc Nurs Ment Health Serv. 2014 Jan;52(1):12-5
Date
Jan-2014
Language
English
Publication Type
Article
Keywords
Amines - adverse effects - classification
Controlled Substances - classification
Cyclohexanecarboxylic Acids - adverse effects - classification
Female
Great Britain - epidemiology
Humans
Incidence
Male
Norway - epidemiology
Prescription Drug Misuse - adverse effects - statistics & numerical data
Risk assessment
Scotland - epidemiology
Substance Withdrawal Syndrome - epidemiology - etiology - prevention & control
Substance-Related Disorders - epidemiology - etiology
gamma-Aminobutyric Acid - adverse effects - classification
Abstract
Gabapentin, a gamma-aminobutyric acid analog drug, appears to be safe and efficacious for the treatment of alcohol dependence. Gabapentin is not a controlled drug, but there are anecdotal reports of its misuse and abuse as well as reports of withdrawal symptoms associated with abrupt discontinuation. The risk of gabapentin misuse is inconsistent, the magnitude of the risk is small, and the risk is not comparable to the much higher risks associated with alcohol use; benzodiazepine, opioid, and stimulant drug use; or illicit drug use. Reports of gabapentin misuse are not unique to this drug, as misuse of prescription medications not typically considered "drugs of abuse" can also occur.
PubMed ID
24596960 View in PubMed
Less detail